Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
a technology of unsaturated fatty acids and releasing compounds, which is applied in the direction of drug compositions, phosphorous compound active ingredients, metabolic disorders, etc., can solve the problems of reduced learning rate, cognitive impairment of aging or aging animals, and associated cognitive impairment, so as to enhance cognitive function in an animal
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Benefits of technology
Problems solved by technology
Method used
Examples
example 1
Animal and Test Groups
[0125]Cognitively-experienced beagle dogs (males and females ranging from 7.5 to 11.6 years of age) were tested. The average age of the dogs was 9.38 years. To qualify, the dogs must have had at least 6 months of previous cognitive test experience, including having been trained on the delayed non-matching-to position task (DNMP) and the oddity task.
[0126]During an initial baseline phase, all dogs were tested on a variable delay version of the DNMP task (or at 5 s if previously unable to learn the task) that provided a means of assessing visuo-spatial working memory and on a size discrimination and reversal task. Performance on these tasks was used to place the dogs into four cognitively equivalent treatment groups (twelve dogs per group): (1) 2% fish oil, 2.5% arginine, 1 to 40 times RDA B vitamins, 150 mg / kg vitamin C, 900 mg / kg vitamin E, and 0.5 mg / kg selenium (“SPB Group”); and (2) the Control Group.
Feeding and Water
[0127]Dogs had free access to water via w...
example 2
[0148]Male Charles Rivers Sprague-Dawley rats (250 g, Wilmington, Mass.) were acclimatized to animal facilities 3 days prior to surgery with a 12 hour light-dark cycle. Bilateral ovariectomy was performed 2 weeks before diet feeding began. Four weeks after the start of diet feeding, transient middle cerebral artery (tMCA) occlusion under anesthesia was performed following intraperitoneal injection of ketamine (60 mgkg) and xylazine (10 mg / kg). 15 rats per group were randomly assigned to one of four treatment groups:
[0149]Group 1—Neutered+Control Diet
[0150]Group 2—Neutered+Diet II
[0151]Group 3—Intact+Control Diet
[0152]Group 4—Intact+Diet II
[0153]The Control Diet was a standard rat diet containing 140 g / kg casein, 100 g / kg sucrose, 50 g / kg fiber, 155 g / kg dextrin, 466 g / kg corn starch, 35 g / kg standard salt mix, 40 g / kg soybean oil, 10 g / kg standard vitamin mix, 1.8 g / kg L-cystine and 2.5 g / kg choline chloride. Diet II was the Control Diet plus 2% Arginine, 2% Menhaden fish oil 4× B v...
PUM
Property | Measurement | Unit |
---|---|---|
time | aaaaa | aaaaa |
digestibility | aaaaa | aaaaa |
diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com